![Roberto Bellini](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roberto Bellini
Director Ejecutivo en BELLUS HEALTH .
Cargos activos de Roberto Bellini
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BELLUS HEALTH | Director/Miembro de la Junta | 05/06/2009 | - |
Director Ejecutivo | 06/01/2010 | - | |
Presidente | 06/01/2010 | - | |
Contacto de Relaciones con Inversores | 05/06/2009 | 20/02/2012 | |
Public Communications Contact | 23/07/2010 | 20/02/2012 | |
Corporate Officer/Principal | 07/06/2009 | 06/01/2010 | |
BIOTECanada
![]() BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Director/Miembro de la Junta | 04/05/2016 | - |
FB Dermatology Ltd.
![]() FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | Director/Miembro de la Junta | - | - |
Historial de carrera de Roberto Bellini
Antiguos cargos conocidos de Roberto Bellini.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
THALLION PHARMACEUTICALS INC. | Director/Miembro de la Junta | 01/03/2007 | 24/04/2013 |
Independent Dir/Board Member | 01/03/2007 | 24/04/2013 | |
Picchio Pharma, Inc.
![]() Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Picchio Pharma, Inc. engages in acquiring, developing, and commercializing new therapeutic products and technologies. The company was founded in 2001 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 01/11/2006 | 01/12/2009 |
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | - | - |
CellCarta Biosciences, Inc.
![]() CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Director/Miembro de la Junta | - | - |
Formación de Roberto Bellini.
McGill University | Undergraduate Degree |
Estadísticas
Internacional
Canadá | 8 |
Irlanda | 2 |
Operativa
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 1 |
Sectorial
Health Technology | 7 |
Commercial Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 7 |
---|---|
CellCarta Biosciences, Inc.
![]() CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Commercial Services |
Thallion Pharmaceuticals, Inc.
![]() Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thallion Pharmaceuticals, Inc. is a biotechnology company focused on developing new pharmaceutical products in the areas of infectious disease and oncology. Its products are Shigamabs, a dual antibody product for the treatment of Shigatoxin-producing E. coli bacterial infections and TLN-4601, a proprietary first in class small molecule with potential efficacy in multiple oncology indications. The company was founded in January 1998 and is headquartered in Dorval, Canada. | Health Technology |
BELLUS Health, Inc.
![]() BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
Picchio Pharma, Inc.
![]() Picchio Pharma, Inc. Pharmaceuticals: GenericHealth Technology Picchio Pharma, Inc. engages in acquiring, developing, and commercializing new therapeutic products and technologies. The company was founded in 2001 and is headquartered in Laval, Canada. | Health Technology |
Prognomix, Inc.
![]() Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
BIOTECanada
![]() BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
FB Dermatology Ltd.
![]() FB Dermatology Ltd. Pharmaceuticals: OtherHealth Technology FB Dermatology Ltd. is a med-tech company, which focuses on developing and exploring patented bio-photonic technology using fluorescent light energy to stimulate the skin’s own biological processes and repair mechanisms. Its products include Kleresca acne treatment, Kleresca skin rejuvenation, Kleresca rosacea treatment, and Kleresca pre-post Treasureratment. The company is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Roberto Bellini
- Experiencia